Zoetis Inc (ZTS) is AMI Asset Management Corp’s 4th Largest Position
AMI Asset Management Corp trimmed its stake in Zoetis Inc (NYSE:ZTS) by 3.7% in the 4th quarter, HoldingsChannel reports. The firm owned 590,837 shares of the company’s stock after selling 22,822 shares during the period. Zoetis makes up 2.9% of AMI Asset Management Corp’s portfolio, making the stock its 4th largest holding. AMI Asset Management Corp’s holdings in Zoetis were worth $42,564,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its stake in Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock worth $100,000 after buying an additional 230 shares in the last quarter. Steward Partners Investment Advisory LLC purchased a new stake in Zoetis in the 3rd quarter worth $114,000. Harfst & Associates Inc. increased its stake in Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock worth $117,000 after buying an additional 260 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in Zoetis by 251.9% in the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after buying an additional 1,360 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. increased its stake in Zoetis by 86.5% in the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock worth $143,000 after buying an additional 1,040 shares in the last quarter. Hedge funds and other institutional investors own 93.14% of the company’s stock.
Shares of Zoetis Inc (NYSE:ZTS) traded up $0.15 during trading hours on Tuesday, hitting $75.54. 2,585,084 shares of the company were exchanged, compared to its average volume of 2,390,510. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45. Zoetis Inc has a 1 year low of $52.00 and a 1 year high of $76.40. The company has a market cap of $36,810.00, a P/E ratio of 39.76, a price-to-earnings-growth ratio of 1.90 and a beta of 1.06.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be issued a $0.126 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.67%. Zoetis’s dividend payout ratio (DPR) is presently 22.11%.
A number of equities research analysts have issued reports on ZTS shares. BMO Capital Markets set a $65.00 price target on Zoetis and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research downgraded shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price objective for the company. in a report on Saturday. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 price objective on shares of Zoetis in a report on Tuesday, October 24th. BidaskClub downgraded shares of Zoetis from a “hold” rating to a “sell” rating in a report on Friday, October 6th. Finally, Cowen set a $80.00 price objective on shares of Zoetis and gave the company a “buy” rating in a report on Friday, November 17th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $71.94.
WARNING: This news story was first reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/zoetis-inc-zts-is-ami-asset-management-corps-4th-largest-position/1809729.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.